MARCH 8-11, 2019Memorial Sloan Kettering Cancer CenterZuckerman Research CenterNew York

7th Annual Hematology and Medical Oncology Board Review: CONTEMPORARY PRACTICE

Memorial Sloan Kettering Cancer Center is pleased to announce the

This four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.

Target Audience

The target audience for this course is medical oncology professionals, including physicians, nurses, pharmacists, fellows and residents.

Educational Objectives

• Learn state-of-the-science in diagnosis, staging, and therapeuticmanagement of solid tumor cancers

• Learn state-of-the-science in diagnosis, staging, and therapeuticmanagement of hematologic cancers

• Understand recent treatment advances in solid tumor andhematologic oncology and their impact on modern clinical practice

David H. Ilson, MD, PhDAttending Physician, Gastrointestinal Oncology ServiceDivision of Solid Tumor OncologyDepartment of MedicineMember, Memorial Sloan Kettering Cancer CenterProfessor of Medicine, Weill Cornell Medical College

Paul A. Hamlin, MDMedical Director, David H. Koch Center for Cancer CareAssociate Attending, Lymphoma Service Division of Hematologic Malignancies Department of MedicineAssociate Professor of Medicine, Weill Cornell Medical College

MSK Course Directors

7th Annual Hematology and Medical Oncology Board Review: CONTEMPORARY PRACTICE

#MSKHemOncCME

COURSE OVERVIEW

Ghassan K. Abou-Alfa, MD, MBAAttending Physician Gastrointestinal Oncology Service Division of Solid Tumor Oncology Department of Medicine

Carol Aghajanian, MDAttending Physician, ChiefGynecologic Medical Oncology Service Division of Solid Tumor OncologyDepartment of Medicine

Dean F. Bajorin, MD, FACPAttending PhysicianGenitourinary Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Renier J. Brentjens, MD, PhDDirector, Cellular Therapeutics CenterAssociate AttendingLeukemia ServiceDivision of Hematologic OncologyDepartment of Medicine

Andrea Cercek, MDAssistant Attending PhysicianGastrointestinal Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Paul B. Chapman, MDAttending PhysicianMelanoma and Immunotherapeutics serviceDivision of Solid Tumor OncologyDepartment of Medicine

Hiram S. Cody III, MD, FACSAttending SurgeonBreast ServiceDepartment of SurgeryProfessor of Surgery, Weill Cornell Medical College

Chau T. Dang, MDChief, West Harrison Medical Oncology ServiceBreast Medicine ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Mark A. Dickson, MDAssociate Attending PhysicianSarcoma Medical Oncology Service Division of Solid Tumor OncologyDepartment of Medicine

Darren R. Feldman, MDAssistant Attending PhysicianGenitourinary Oncology ServiceBone Marrow Transplant ServiceAssistant Professor of Medicine, Weill Cornell Medical College

Devika Gajria, MDAssistant AttendingBreast Medicine ServiceDepartment of Medicine

Rachel N. Grisham, MD Assistant Attending PhysicianGynecologic Medical Oncology ServiceDepartment of Medicine

Mrinal M. Gounder, MDAssistant Attending PhysicianSarcoma Medical Oncology ServiceEarly Drug Development ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Christian Grommes, MDAssistant Attending PhysicianBrain Tumor ServiceDepartment of Neurology

Komal Jhaveri, MD, FACPAttendingBreast Medicine Service and Early Drug Development ServiceDepartment of Medicine

Philip Kantoff, MDChairman, Department of MedicineProfessor of Medicine, Weill Cornell Medical College

C. Ola Landgren, MD, PhDChief, Myeloma ServiceDivision of Hematologic OncologyDepartment of Medicine

Bob T. Li, MD, MPHAssistant Attending PhysicianThoracic Oncology ServiceDevelopmental TherapeuticsDivision of Solid Tumor OncologyDepartment of Medicine

Simon Mantha, MD, MPHAssociate Attending Physician Hematology ServiceDivision of Hematologic OncologyDepartment of Medicine

MSK Course Faculty Michael J. Mauro, MDAttending PhysicianLeukemia ServiceDivision of Hematologic OncologyDepartment of Medicine

Beryl McCormick, MD, FACRChief, External Beam Radiotherapy ServiceDepartment of Radiation OncologyProfessor of Radiation Oncology, Weill Cornell Medical College

Jodi Mones, MDAssociate AttendingHematology ServiceDivision of Hematologic OncologyDepartment of Medicine

Alison J. Moskowitz, MDClinical Director, Lymphoma Inpatient Unit Assistant AttendingLymphoma ServiceDepartment of Medicine

Robert J. Motzer, MDAttending PhysicianGenitourinary Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Eileen M. O’Reilly, MDAssociate Director for Clinical Research, David M. Rubenstein Center for Pancreatic CancerAttending PhysicianGastrointestinal Oncology ServiceDivision of Solid Tumor Oncology Department of MedicineMember, Memorial Sloan Kettering Cancer CenterProfessor of Medicine, Weill Cornell Medical College

Rekha Parameswaran, MDAssociate AttendingHematology ServiceDepartment of Medicine

David G. Pfister, MDAttending Physician, ChiefHead and Neck Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Gregory J. Riely, MD, PhDVice Chair, Clinical ResearchAssociate Attending PhysicianThoracic Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Leonard B. Saltz, MDExecutive Director for Clinical Value and SustainabilityAttending PhysicianGastrointestinal Oncology ServiceDivision of Solid Tumor OncologyDepartment of MedicineProfessor of Medicine, Weill Cornell Medical College

Craig S. Sauter, MDAssistant AttendingBone Marrow Transplant ServiceDepartment of Medicine

Susan Seo, MDAttending PhysicianInfectious Disease serviceDivision of General MedicineDepartment of Medicine

Gerald A. Soff, MDChief, Hematology ServiceDivision of Hematologic OncologyDepartment of Medicine

Zsofia K. Stadler, MDClinical Director, Clinical Genetics ServiceAssociate Attending PhysicianClinical Genetics and Gastrointestinal Oncology ServicesDivision of Solid Tumor OncologyDepartment of Medicine

Martin S. Tallman, MDChief, Leukemia ServiceDivision of Hematologic OncologyDepartment of Medicine

Anna M. Varghese, MDAssistant Attending PhysicianGastrointestinal Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Marjorie G. Zauderer, MDCo-Director MSK Mesothelioma ProgramAssistant Attending PhysicianThoracic Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Andrew D. Zelenetz, MD, PhDMedical Director, Quality InformaticsAttending PhysicianLymphoma ServiceDivision of Hematologic OncologyDepartment of Medicine

7:00 am Breakfast

Pharmacology Session

7:30 am Pharmacology I Mrinal M. Gounder, MD

8:15 am Pharmacology II Mrinal M. Gounder, MD

9:20 am Break

Hematology Session

9:30 amThrombocytopenia, ITP and Beyond Gerald Soff, MD

10:30 am Low Grade NHL/CLL Andrew D. Zelenetz, MD, PhD

11:30 am DLBCL/MCL/BL Paul Hamlin, MD

12:30 pm Lunch

1:15 pm HL/T Cell Alison J. Moskowitz, MD

2:15 pm Auto/Allo Craig S. Sauter, MD

3:15 pm AML/ALL Martin S. Tallman, MD

4:15 pm Break

4:30 pm MDS/MPN Michael J. Mauro, MD

5:30 pm Myeloma/Amyloid C. Ola Landgren, MD, PhD

6:30 pm Adjourn

Day 3 | Sunday, March 10

7:30 am Breakfast

8:00 am CART cells Renier J. Brentjens, MD, PhD

9:00 amThe Role of the Direct Oral Anticoagulants in Practice Simon Mantha, MD, MPH

10:00 am Approach to The Bleeding Patient Rekha Parameswaran, MD

11:00 am Sickle Cell Disease, Thalassemia Jodi Mones, MD

12:00 pm Adjourn

Day 4 | Monday, March 11

8:30 am Breakfast and Registration

Solid Tumor Session

9:00 am Colon Cancer Leonard B. Saltz, MD

10:00 am Melanoma Paul B. Chapman, MD

10:45 am Prostate Cancer Philip Kantoff, MD

11:30 am Kidney Cancer Robert J. Motzer, MD

12:15 pm Mesothelioma Marjorie G. Zauderer, MD

12:30 pm Lunch

1:15 pm Urothelial Cancer Dean F. Bajorin, MD, FACP

2:00 pm Testis Cancer Darren R. Feldman, MD

2:45 pm Uterine/Cervix/Other GYN Cancers Carol Aghajanian, MD

3:30 pm Break

3:45 pm Ovarian Cancer Rachel N. Grisham, MD

4:30 pm Breast Cancer/Surgery Hiram S. Cody III, MD, FACS

5:00 pm Breast Cancer/Radiation Therapy Beryl McCormick, MD, FACR

5:30 pm Esophageal and Gastric Cancer David H. Ilson, MD, PhD

6:00 pm Adjourn

6:30 am Breakfast

7:00 am Small Cell Lung Cancer Bob T. Li, MD, MPH

7:30 am Breast Cancer/Advanced Disease Komal Jhaveri, MD, FACP

8:30 am Breast Cancer/Adjuvant Therapy Chau T. Dang, MD

9:30 am Breast Cancer/Hormonal Therapy Devika Gajria, MD

10:00 am Carcinoma of Unknown Primary Anna M. Varghese, MD

10:30 am Break

10:45 amHepatocellular Cancer and Cholangiocarcinoma Ghassan K. Abou-Alfa, MD, MBA

11:30 amPancreatic and Neuroendocrine Cancer Eileen M. O’Reilly, MD

12:15 pm Lunch

1:15 pm Non Small Cell Lung Cancer Gregory J. Riely, MD, PhD

2:00 pm Head and Neck, Thyroid Cancer David G. Pfister, MD

2:45 pm Anal/Rectal Cancer Andrea Cercek, MD

3:15 pm Break

Day 1 | Friday, March 8

Day 2 | Saturday, March 9

COURSE SCHEDULE

3:30 pm Genetics Zsofia K. Stadler, MD

4:00 pm CNS Tumors Christian Grommes, MD

4:30 pm Sarcoma Mark A. Dickson, MD

5:00 pm Infectious Disease Susan Seo, MD

5:30 pm Adjourn

mskcc.org/HemOncBoardReviewLive Simulcast Available!

Visit mskcc.org/HemOncBoardReview for more information.

REGISTRATION FEES

Physicians (MDs, PhDs and DOs) $1500

Residents, Fellows, Nurses and Other Healthcare Providers $975

Industry Professionals* $2,525

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Course registration includes continental breakfast, lunch, and refreshment breaks. Please contact cme@mskcc.org at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

• MSK CME offers a 30% discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact cme@mskcc.org for more information.

• MSK employee registration is complimentary. However, you must complete course registration in order to attend this course.

AccreditationMemorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation StatementMemorial Sloan Kettering Cancer Center designates this live activity for a maximum of 30.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition StatementSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 30.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

REGISTRATION

Faculty DisclosureIt is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it provides as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity provided by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for anypurpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.

Conference Location & AccommodationsZuckerman Research Center417 East 68th Street New York, NY 10065

MSK has negotiated special rates and amenities at select hotels in Manhattan. For information on hotels in the vicinity of MSK with discounted rates, please visit: mskcc.org/cme.

ContactMemorial Sloan Kettering Cancer CenterOffice of Continuing Medical Educationmskcc.org/cmecme@mskcc.org

Register online:mskcc.org/HemOncBoardReview

ZUCKERMAN RESEARCH CENTER

#MSKHemOncCME

Live Simulcast Available!Visit mskcc.org/HemOncBoardReview for more information.